199 related articles for article (PubMed ID: 24641440)
1. Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.
Baliga RS; Scotton CJ; Trinder SL; Chambers RC; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2014 Jul; 171(14):3463-75. PubMed ID: 24641440
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.
Zhao L; Mason NA; Strange JW; Walker H; Wilkins MR
Circulation; 2003 Jan; 107(2):234-7. PubMed ID: 12538421
[TBL] [Abstract][Full Text] [Related]
4. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
Okamoto A; Nojiri T; Konishi K; Tokudome T; Miura K; Hosoda H; Hino J; Miyazato M; Kyomoto Y; Asai K; Hirata K; Kangawa K
Respir Res; 2017 Jan; 18(1):1. PubMed ID: 28049526
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Bubb KJ; Trinder SL; Baliga RS; Patel J; Clapp LH; MacAllister RJ; Hobbs AJ
Circulation; 2014 Aug; 130(6):496-507. PubMed ID: 24899690
[TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
Kimura T; Nojiri T; Hino J; Hosoda H; Miura K; Shintani Y; Inoue M; Zenitani M; Takabatake H; Miyazato M; Okumura M; Kangawa K
Respir Res; 2016 Feb; 17():19. PubMed ID: 26895702
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
Milara J; Escrivá J; Ortiz JL; Juan G; Artigues E; Morcillo E; Cortijo J
Eur Respir J; 2016 Jun; 47(6):1737-49. PubMed ID: 27009174
[TBL] [Abstract][Full Text] [Related]
9. Adrenomedullin Ameliorates Pulmonary Fibrosis by Regulating TGF-ß-Smads Signaling and Myofibroblast Differentiation.
Wei Y; Tanaka M; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Cui N; Kakihara S; Zhao Y; Aruga K; Sanjo H; Shindo T
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33955458
[TBL] [Abstract][Full Text] [Related]
10. Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats.
Schroll S; Lange TJ; Arzt M; Sebah D; Nowrotek A; Lehmann H; Wensel R; Pfeifer M; Blumberg FC
Acta Physiol (Oxf); 2013 Jun; 208(2):191-201. PubMed ID: 23527830
[TBL] [Abstract][Full Text] [Related]
11. Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
Avouac J; Konstantinova I; Guignabert C; Pezet S; Sadoine J; Guilbert T; Cauvet A; Tu L; Luccarini JM; Junien JL; Broqua P; Allanore Y
Ann Rheum Dis; 2017 Nov; 76(11):1931-1940. PubMed ID: 28801346
[TBL] [Abstract][Full Text] [Related]
12. Regulation of myofibroblast differentiation and bleomycin-induced pulmonary fibrosis by adrenomedullin.
Kach J; Sandbo N; Sethakorn N; Williams J; Reed EB; La J; Tian X; Brain SD; Rajendran K; Krishnan R; Sperling AI; Birukov K; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L757-64. PubMed ID: 23585227
[TBL] [Abstract][Full Text] [Related]
13. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.
Tam AYY; Horwell AL; Trinder SL; Khan K; Xu S; Ong V; Denton CP; Norman JT; Holmes AM; Bou-Gharios G; Abraham DJ
Int J Biochem Cell Biol; 2021 May; 134():105961. PubMed ID: 33662577
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung.
Chang J; Nie H; Ge X; Du J; Liu W; Li X; Sun Y; Wei X; Xun Z; Li YC
Sci Rep; 2021 Aug; 11(1):16525. PubMed ID: 34400742
[TBL] [Abstract][Full Text] [Related]
15. Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.
Reddy AT; Lakshmi SP; Zhang Y; Reddy RC
FASEB J; 2014 Dec; 28(12):5299-310. PubMed ID: 25252739
[TBL] [Abstract][Full Text] [Related]
16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
17. Relaxin regulates myofibroblast contractility and protects against lung fibrosis.
Huang X; Gai Y; Yang N; Lu B; Samuel CS; Thannickal VJ; Zhou Y
Am J Pathol; 2011 Dec; 179(6):2751-65. PubMed ID: 21983071
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
20. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
